What is a Patient Group Direction and how can these help the health service at this moment in time?
According to the NHS, Patient Group Directions (PGDs) provide a legal framework that allows some registered health professionals to supply and/or administer specified medicines to a pre-defined group of patients, without them having to see a prescriber (such as a doctor or nurse prescriber).
This has obvious benefits, certainly during the COVID-19 outbreak. By charging other suitably-qualified healthcare professionals with the responsibility of providing these medications to patients who require them, this reduces prescribing pressures on GP’s.
By enabling other healthcare professionals to issue these products under a Patient Group Direction, it can also speed up the process of patients receiving their required medications as there’s no delay in waiting for a GP to sign off on a prescription.
Issuing catheterisation gel under a Patient Group Direction
The OptiLube range of catheterisation gels can be issued under a PGD. These catheterisation gels are registered medical devices and can be found on part IXA-Appliances on the Drug Tariff. As well as having the ease of being able to prescribe them under a PGD, these catheterisation jelly syringes can also provide cost savings against other brands.
The OptiLube catheterisation jelly range includes…
- OptiLube Active with Lidocaine 2% and Chlorhexidine 0.05%
- OptiLube Active CHG Free with Lidocaine 2%
- OptiLube without active ingredients
By providing a choice of gels, clinicians are able to select the most appropriate catheterisation gel for each patient based on an individualised assessment. Each format is available in 6ml and 11ml volumes, provided in a sterile, pre-filled syringe.
To find out more about the benefits of using our catheterisation jelly range, please email email@example.com or call 0113 263 3849.